Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics
de
Few & Far Between: Conversations from the Front Lines of Drug Development
2024-10-23 09:08:00
Fecha de lanzamiento
44:29
Duración
